https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/Enhertu-approved-in-the-EU-for-patients-with-HER2-positive-metastatic-breast-cancer-treated-with-one-41021675/?utm_source=telegram&utm_medium=social&utm_campaign=share